SPC286
Gilteritinib eða salt þar af
Status:
VeittApplication date:
29.1.2020Application published:
15.2.2020Grant published:
15.8.2020
Max expiry date:
27.10.2034Medicine name:
XospataMedicine for children:
No
Timeline
Today
29.1.2020Application
15.2.2020Publication
15.8.2020Registration
27.10.2034Expires
Marketing license
IS authorization number:
EU/1/19/1399/001Date:
6.11.2019
Foreign authorization number:
EU/1/19/1399Date:
24.10.2019
Owner
Name:
Astellas Pharma Inc.Address:
5-1, Nihonbashi-Honcho 2-chome, Chuo-kuTokyo JP
Name:
Kotobuki Pharmaceutical Co., Ltd.Address:
6351, Oaza Sakaki Sakaki-machi, Hanishina-gun, Nagano JP
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105 Reykjavík
Patent
Number:
EP2428508